IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing therapeutics for female cancers.
Industry: Health Care
Latest Trade: $1.38 0.00 (0.0%)
First Day Return: +2.0%
Return from IPO: -72.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/27/2021 |
Offer Price | $5.00 |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/19/2021 |
Offer Price | $5.00 |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
ThinkEquity |
Company Data | |
---|---|
Headquarters | Philadelphia, PA, United States |
Founded | 2015 |
Employees | 2 |
Website www.contexttherapeutics.com |